This study by Chien-Te Tseng et al. in PLOS, 2012, SEMINAL but they covered it up: "Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"
The findings were critical and pay attention to what I highlight for in 2012 it gave us the road map of what was to come if we played around with the coronavirus vaccine
It is beyond vaccination, it is what happens post vaccine when challenged and exposed in the natural environment which you would be for you live among pathogen and an ongoing pandemic.
This animal ferret mouse study showed us in 2012, that we were to be careful and NOT just bring the vaccine. We were warned but they went ahead and the key issue is this line “Because of a concern for reemergence or a deliberate release of the SARS coronavirus”…they were talking about ‘deliberate’ release…this was the animal mice model. Also this line “These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.”
Abstract
Background: Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologic-type lung disease.
Design: Four candidate vaccines for humans with or without alum adjuvant were evaluated in a mouse model of SARS, a VLP vaccine, the vaccine given to ferrets and NHP, another whole virus vaccine and an rDNA-produced S protein. Balb/c or C57BL/6 mice were vaccinated i.m. on day 0 and 28 and sacrificed for serum antibody measurements or challenged with live virus on day 56. On day 58, challenged mice were sacrificed and lungs obtained for virus and histopathology.
Results: All vaccines induced serum neutralizing antibody with increasing dosages and/or alum significantly increasing responses. Significant reductions of SARS-CoV two days after challenge was seen for all vaccines and prior live SARS-CoV. All mice exhibited histopathologic changes in lungs two days after challenge including all animals vaccinated (Balb/C and C57BL/6) or given live virus, influenza vaccine, or PBS suggesting infection occurred in all. Histopathology seen in animals given one of the SARS-CoV vaccines was uniformly a Th2-type immunopathology with prominent eosinophil infiltration, confirmed with special eosinophil stains. The pathologic changes seen in all control groups lacked the eosinophil prominence.
Conclusions: These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.
Thanks Dr Alexander… I was listening to Dr Dolores Cahill, Dr Sucharit Bhakdi and Dr Wolfgang Wodarg saying this exact same thing in April of 2020….. do you know them? We are all on the exact same page here and the sooner the medical community at the Top of our corrupted medical hierarchy finally puts the patients before profit and stops these catastrophic mRNA drugs the better!
Similar to RSV. Th2-type immunopathologic reaction in young children given an inactivated RSV vaccine and subsequently infected with naturally-occurring RSV. Most of these children experienced severe disease with infection that led to a high frequency of hospitalizations; two children died from the infection. The conclusion from that experience was clear; RSV lung disease was enhanced by the prior vaccination.